Stockreport

Dupixent “addresses current gap” in COPD biologics landscape [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF The European Medicines Agency (EMA) greenlit the anti-inflammatory blockbuster drug earlier this week, marking the first advancement in the COPD space in more than a de [Read more]